CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-13 | Silver Brian M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +632,500 | 632,500 | ||
| 2022-12-28 | Silver Brian M. Chief Financial Officer | Purchase | +3,158 | $1.56 | $5K | 32,885 |
| 2022-12-27 | Silver Brian M. Chief Financial Officer | Purchase | +2,842 | $1.50 | $4K | 29,727 |
| 2022-07-25 | Silver Brian M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2022-03-24 | Silver Brian M. Chief Financial Officer | Purchase | +15,000 | $3.40 | $51K | 26,885 |
| 2022-01-18 | Silver Brian M. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2021-09-21 | Silver Brian M. Chief Financial Officer | Purchase | +5,000 | $6.32 | $32K | 11,885 |
| 2021-09-09 | Silver Brian M. Chief Financial Officer | Purchase | +5,885 | $8.48 | $50K | 6,885 |
| 2021-07-20 | Silver Brian M. Chief Financial Officer | Purchase | +1,000 | $15.00 | $15K | 1,000 |
| 2021-07-15 | Silver Brian M. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +250,441 | 250,441 |
Page 1 of 1 · 10 trades